{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/5-mapb/federal/","compound":{"slug":"5_mapb","name":"5-MAPB"},"federal":[{"form":"all","status":"gray","headline":"Unscheduled by name; Schedule I by Federal Analogue Act when intended for human consumption","tier":"analog_exposed","schedule_class":null,"effective_date":"1986-10-27","verified_at":"2026-07-20","citations":[{"title":"21 U.S.C. 802(32) -- definition of 'controlled substance analogue'","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section802&num=0&edition=prelim","pinpoint":null,"primary":true},{"title":"21 U.S.C. 813 -- treatment of controlled substance analogues","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section813&num=0&edition=prelim","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 -- Schedule I (hallucinogenic substances, subsec. (d))","url":"https://www.ecfr.gov/current/title-21/chapter-II/part-1308/section-1308.11","pinpoint":null,"primary":true},{"title":"Federal Register full-text search -- term '5-MAPB' (DEA/DOJ)","url":"https://www.federalregister.gov/documents/search?conditions%5Bterm%5D=5-MAPB","pinpoint":null,"primary":true},{"title":"21 U.S.C. 802(32) & 21 U.S.C. 813","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section813&num=0&edition=prelim","pinpoint":null,"primary":true},{"title":"WHO ECDD List of Substances under Surveillance 2024 (5-MAPB monitored, not UN-scheduled)","url":"https://cdn.who.int/media/docs/default-source/controlled-substances/47th-ecdd/2024-who-substances-under-surveillance.pdf","pinpoint":null,"primary":false}]}]}